CLL: Bruton’s TKIs Succeed Against TP53 Alterations
First-line treatment demonstrates efficacy ATLANTA—Patients diagnosed with chronic...
Read MoreDec 15, 2021
First-line treatment demonstrates efficacy ATLANTA—Patients diagnosed with chronic...
Read MoreDec 15, 2021
Mortality, MACE similar with shorter stays for low-risk patients Low-risk patients were discharged...
Read MoreDec 15, 2021
Few patients had disease progression, and most gained clinical benefit ATLANTA—The novel...
Read MoreDec 15, 2021
Two recent randomized trials show success with metoprolol and mavacamten Results from two...
Read MoreDec 15, 2021
D-dimer thresholds that depend on pretest probability of PE had highest efficiency, but highest...
Read MoreDec 15, 2021
Investigational device combines leadless pacemaker with a subcutaneous ICD to reach more patients...
Read MoreDec 15, 2021
XPO1 inhibitor plus daratumumab, bortezomib, and dexamethasone shows promise ATLANTA—A...
Read MoreDec 14, 2021
Ibrutinib plus venetoclax allows drug-free remission ATLANTA—After two years of follow-up,...
Read MoreDec 14, 2021
A challenge to standard of care for transplant-eligible patients? ATLANTA—Adding an...
Read MoreDec 14, 2021
Drug-free for 12 months ATLANTA—Patients diagnosed with relapsed or treatment refractory...
Read MoreDec 14, 2021
Study finds ’deepening of response’ after 4 cycles ATLANTA—The depth of response...
Read MoreDec 14, 2021
Findings consistent with earlier data about adult-onset MS More outdoor time and sun exposure...
Read MoreDec 14, 2021
Few followed National Academy of Medicine guideline trustworthiness standards Dozens of clinical...
Read MoreDec 14, 2021
Clear difference when compared with chemotherapy in patients with CLL ATLANTA—Twenty months...
Read MoreDec 13, 2021
Women treated by male surgeons may drive the association Does sex matter when it comes to surgery...
Read MoreDec 13, 2021
Reducing disparities in care, incorporating a Heart Team among top recommmendations The American...
Read MoreDec 13, 2021
Schedules with at least 1 mRNA dose produced best response Mixing—instead of...
Read MoreDec 13, 2021
Lynne Peterson is the Senior Editor for Trends-in-Medicine.Here is the medical news to watch for...
Read MoreDec 10, 2021
Novel aryl hydrocarbon receptor may be a future steroid alternative Tapinarof 1% cream reduced the...
Read MoreDec 10, 2021
Add-on treatment also improved lung function and asthma control Adding the biologic dupilumab to...
Read More